Please login to the form below

Not currently logged in
Email:
Password:

PKC412

This page shows the latest PKC412 news and features for those working in and with pharma, biotech and healthcare.

Novartis gets speedy FDA review for midostaurin

Novartis gets speedy FDA review for midostaurin

The US regulator has started its review of midostaurin (PKC412) for newly-diagnosed FLT3-mutated acute myeloid leukaemia (AML) and advanced systemic mastocytosis and - if all goes according to plan - the

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics